BRÈVE publiée le 11/06/2026 à 07:05, il y a 15 jours 23 heures Curatis relève ses prévisions de croissance des revenus pour 2026 Croissance Des Revenus Marché Suisse Médicaments Curatis Holding AG Prévisions Pour 2026
BRÈVE publiée le 11/06/2026 à 07:05, il y a 15 jours 23 heures Curatis Raises Revenue Growth Forecast for 2026 Revenue Growth Pharmaceuticals Swiss Market Curatis Holding AG 2026 Forecast
COMMUNIQUÉ DE PRESSE publié le 11/06/2026 à 07:00, il y a 15 jours 23 heures Curatis Increases Revenue Growth Guidance for 2026 Curatis Holding AG increases its revenue growth guidance for 2026 to approximately 40%, up from the previous outlook of over 25%. The growth is driven by existing and new products in the company's portfolio Revenue Growth Switzerland Curatis Holding AG Profit Hike 2026 Forecast
BRÈVE publiée le 22/05/2026 à 18:35, il y a 1 mois 4 jours Curatis Holding AG approuve toutes les propositions du conseil d'administration lors de son assemblée générale annuelle. Assemblée Générale Annuelle Réélection Curatis Holding AG Propositions Du Conseil D'administration Approbation De L'auditeur
BRÈVE publiée le 22/05/2026 à 18:35, il y a 1 mois 4 jours Curatis Holding AG Approves All Board Proposals at AGM Annual General Meeting Re-election Board Proposals Curatis Holding AG Auditor Approval
COMMUNIQUÉ DE PRESSE publié le 22/05/2026 à 18:30, il y a 1 mois 4 jours Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors Curatis Holding AG shareholders approve all Board proposals at Annual General Meeting. Re-election of board members and positive financial year 2025 results Annual General Meeting Re-election Board Proposals Curatis Holding AG Financial Year 2025
BRÈVE publiée le 22/05/2026 à 07:05, il y a 1 mois 4 jours Curatis Holding AG Secures CHF 3.0 Million from Swiss Investor Private Placement Clinical Development Curatis Holding AG Corticorelin CHF 3.0 Million
BRÈVE publiée le 22/05/2026 à 07:05, il y a 1 mois 4 jours Curatis Holding AG obtient 3 millions de francs suisses d'un investisseur suisse Placement Privé Développement Clinique Curatis Holding AG Corticoréline 3 Millions De Francs Suisses
COMMUNIQUÉ DE PRESSE publié le 22/05/2026 à 07:00, il y a 1 mois 4 jours Curatis Holding AG announces CHF 3.0 million private placement with strategic investor Curatis Holding AG announces CHF 3.0 million private placement with strategic investor for clinical development of corticorelin drug Private Placement Clinical Development Strategic Investor Curatis Holding AG Corticorelin
BRÈVE publiée le 24/03/2026 à 07:05, il y a 3 mois 2 jours Curatis Reports Significant Revenue Growth and Progress in Corticorelin Development Financial Results Revenue Growth FDA Approval Curatis Corticorelin
Publié le 26/06/2026 à 17:45, il y a 12 heures 44 minutes Descriptif du programme de rachat d'actions
Publié le 27/06/2026 à 01:40, il y a 4 heures 49 minutes Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 6 heures 29 minutes Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 7 heures 29 minutes Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 7 heures 39 minutes Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 8 heures 14 minutes Revive Therapeutics Announces Proposed Private Placement
Publié le 27/06/2026 à 00:05, il y a 6 heures 24 minutes EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 6 heures 25 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 6 heures 53 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 6 heures 53 minutes EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 7 heures 2 minutes EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
